Literature DB >> 15227066

Spiral vein bypass for superior vena cava syndrome due to mediastinal fibrosis.

W T Mattingly1, W E Childers, W R Stauffer.   

Abstract

A 22-year-old man underwent palliative surgery for superior vena cava syndrome due to a benign obstructive process compatible with fibrosing mediastinitis. By using a spiral vein constructed from autologous saphenous vein, an innominate vein to the right atrial appendage shunt was created. This technique, which was first described experimentally in 1974 and performed clinically in 1976, may warrant more liberal application in patients with superior vena cava syndrome caused by malignant and benign diseases.

Entities:  

Year:  1984        PMID: 15227066      PMCID: PMC341731     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  5 in total

1.  Superior vena cava bypass.

Authors:  J C Trainini; R Auricchio; H A del Bagno; V Federico; M W Acrich; J N Osorio
Journal:  Tex Heart Inst J       Date:  1983-06

2.  Replacement of superior vena cava with the spiral composite vein graft. A versatile technique.

Authors:  C J Chiu; J Terzis; M L MacRae
Journal:  Ann Thorac Surg       Date:  1974-06       Impact factor: 4.330

3.  Femoral venous trauma: techniques for surgical management and early results.

Authors:  R W Hobson; R A Yeager; T G Lynch; B C Lee; K Jain; Z Jamil; F T Padberg
Journal:  Am J Surg       Date:  1983-08       Impact factor: 2.565

4.  Bypass of superior vena cava obstruction using spiral vein graft.

Authors:  E R Smith; C O Brantigan
Journal:  J Cardiovasc Surg (Torino)       Date:  1983 May-Jun       Impact factor: 1.888

5.  Bypass of superior vena cava: Six years' experience with spiral vein graft for obstruction of superior vena cava due to benign and malignant disease.

Authors:  D B Doty
Journal:  J Thorac Cardiovasc Surg       Date:  1982-03       Impact factor: 5.209

  5 in total
  1 in total

Review 1.  A reappraisal of saphenous vein grafting.

Authors:  Shi-Min Yuan; Hua Jing
Journal:  Ann Saudi Med       Date:  2011 Jan-Feb       Impact factor: 1.526

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.